Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-08 Sale | 2026-04-10 4:05 pm | Immunovant Inc. | IMVT | Van Tuyl Christopher Chief Legal Officer | 5,165 | $24.83 | $128,247 | 183,231 (Direct) | View |
| 2026-04-08 Sale | 2026-04-10 4:03 pm | Immunovant Inc. | IMVT | Gloria Melanie Chief Operating Officer | 8,722 | $24.83 | $216,567 | 245,222 (Direct) | View |
| 2026-04-08 Sale | 2026-04-10 4:02 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 10,132 | $24.83 | $251,578 | 254,439 (Direct) | View |
| 2026-04-01 Sale | 2026-04-03 4:33 pm | Immunovant Inc. | IMVT | Venker Eric Chief Executive Officer | 349,189 | $25.06 | $8,750,350 | 1,125,811 (Direct) | View |
| 2026-03-18 Sale | 2026-03-20 4:11 pm | Immunovant Inc. | IMVT | Van Tuyl Christopher Chief Legal Officer | 2,877 | $24.97 | $71,839 | 147,053 (Direct) | View |
| 2026-02-25 Sale | 2026-02-27 4:07 pm | Immunovant Inc. | IMVT | Gloria Melanie Chief Operating Officer | 3,238 | $27.85 | $90,184 | 170,273 (Direct) | View |
| 2026-01-21 Sale | 2026-01-23 4:21 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 1,977 | $26.03 | $51,461 | 197,634 (Direct) | View |
| 2026-01-07 Sale | 2026-01-09 4:03 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 1,203 | $26.53 | $31,914 | 199,611 (Direct) | View |
| 2025-12-18 Sale | 2025-12-19 4:05 pm | Immunovant Inc. | IMVT | Van Tuyl Christopher Chief Legal Officer | 10,813 | $26.91 | $290,943 | 149,930 (Direct) | View |
| 2025-12-12 Purchase | 2025-12-12 5:17 pm | Immunovant Inc. | IMVT | Roivant Sciences Ltd. Director 10% Owner | 16,666,666 | $21 | $349,999,986 | 113,317,007 (Direct) | View |
| 2025-12-01 Sale | 2025-12-03 6:14 pm | Immunovant Inc. | IMVT | Fromkin Andrew J. Director | 22,249 | $23.25 | $517,189 | 85,852 (Direct) | View |
| 2025-12-01 Sale | 2025-12-03 6:14 pm | Immunovant Inc. | IMVT | Hughes Douglas J. Director | 15,000 | $23.24 | $348,665 | 120,773 (Direct) | View |
| 2025-11-20 Sale | 2025-11-21 4:24 pm | Immunovant Inc. | IMVT | Gloria Melanie Chief Operating Officer | 12,626 | $23.62 | $298,237 | 173,511 (Direct) | View |
| 2025-10-22 Sale | 2025-10-24 4:38 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 2,595 | $19.03 | $49,383 | 217,958 (Direct) | View |
| 2025-10-22 Sale | 2025-10-24 4:36 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 2,520 | $19.03 | $47,956 | 200,814 (Direct) | View |
| 2025-10-08 Sale | 2025-10-10 4:03 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 1,272 | $16.3 | $20,734 | 220,553 (Direct) | View |
| 2025-10-08 Sale | 2025-10-10 4:01 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 1,585 | $16.3 | $25,836 | 203,334 (Direct) | View |
| 2025-07-23 Sale | 2025-07-25 5:11 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 2,805 | $18.15 | $50,911 | 204,919 (Direct) | View |
| 2025-07-23 Sale | 2025-07-25 5:10 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 2,385 | $18.15 | $43,288 | 221,825 (Direct) | View |
| 2025-07-09 Sale | 2025-07-11 4:15 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 1,160 | $17.24 | $19,998 | 224,210 (Direct) | View |
| 2025-07-09 Sale | 2025-07-11 4:13 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 1,519 | $17.24 | $26,188 | 207,724 (Direct) | View |
| 2025-04-23 Sale | 2025-04-25 4:17 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 1,925 | $14.79 | $28,471 | 209,243 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-07 Option Award | 2026-04-09 4:31 pm | N/A 2036-04-07 | Immunovant Inc. | IMVT | Torti Frank Director | 262,514 | $0 | 1,097,553 (Direct) | View |
| 2026-04-07 Option Award | 2026-04-09 4:28 pm | N/A 2036-04-07 | Immunovant Inc. | IMVT | Fromkin Andrew J. Director | 20,941 | $0 | 106,793 (Direct) | View |
| 2026-04-07 Option Award | 2026-04-09 4:26 pm | N/A 2036-04-07 | Immunovant Inc. | IMVT | Hughes Douglas J. Director | 20,941 | $0 | 141,714 (Direct) | View |
| 2026-04-07 Option Award | 2026-04-09 4:25 pm | N/A 2036-04-07 | Immunovant Inc. | IMVT | Pande Atul Director | 20,941 | $0 | 143,792 (Direct) | View |
| 2026-04-07 Option Award | 2026-04-09 4:23 pm | N/A 2036-04-07 | Immunovant Inc. | IMVT | Bauer Jake Director | 20,941 | $0 | 45,957 (Direct) | View |
| 2026-04-07 Option Award | 2026-04-09 4:22 pm | N/A 2036-04-07 | Immunovant Inc. | IMVT | Susman Robert Graham Director | 20,941 | $0 | 45,957 (Direct) | View |
| 2026-04-07 Option Award | 2026-04-09 4:20 pm | N/A 2036-04-07 | Immunovant Inc. | IMVT | Gloria Melanie Chief Operating Officer | 204,734 | $0 | 375,007 (Direct) | View |
| 2026-04-07 Option Award | 2026-04-09 4:19 pm | N/A 2036-04-07 | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 163,788 | $0 | 361,422 (Direct) | View |
| 2026-04-07 Option Award | 2026-04-09 4:17 pm | N/A 2036-04-07 | Immunovant Inc. | IMVT | Van Tuyl Christopher Chief Legal Officer | 101,163 | $0 | 248,216 (Direct) | View |
| 2026-04-07 Option Award | 2026-04-09 4:13 pm | N/A 2036-04-07 | Immunovant Inc. | IMVT | Venker Eric Chief Executive Officer | 568,295 | $0 | 587,856 (Direct) | View |
| 2026-04-07 Option Award | 2026-04-09 4:10 pm | N/A 2036-04-07 | Immunovant Inc. | IMVT | Girao Tiago Chief Financial Officer | 158,970 | $0 | 367,358 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 4:33 pm | N/A 2030-04-01 | Immunovant Inc. | IMVT | Venker Eric Chief Executive Officer | 368,750 | $0 | 1,125,811 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 4:33 pm | N/A N/A | Immunovant Inc. | IMVT | Venker Eric Chief Executive Officer | 368,750 | $14.46 | 1,125,811 (Direct) | View |
| 2025-07-28 Option Award | 2025-07-30 5:56 pm | N/A 2035-07-28 | Immunovant Inc. | IMVT | Venker Eric Chief Executive Officer | 2,964,900 | $0 | 2,964,900 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 7:30 pm | N/A 2035-05-01 | Immunovant Inc. | IMVT | Girao Tiago Chief Financial Officer | 501,893 | $0 | 501,893 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 7:30 pm | N/A 2035-05-01 | Immunovant Inc. | IMVT | Bauer Jake Director | 60,250 | $0 | 60,250 (Direct) | View |
| 2025-05-01 Option Award | 2025-05-05 7:30 pm | N/A 2035-05-01 | Immunovant Inc. | IMVT | Susman Robert Graham Director | 60,250 | $0 | 60,250 (Direct) | View |